Intraosseous Devices Market

Powered Drill is projected to lead at 42.0% share in 2026, followed by Distal And Proximal Tibia as set to secure 44.0% share of route of administration in 2026. Clinical guideline endorsements for intraosseous access are expected to push hospitals toward powered drill procurement tied to emergency protocol upgrades. Adoption is likely to slow due to clinician training gaps, device cost sensitivity in price-constrained health systems, and limited IO insertion reimbursement clarity.